Canopy Growth Corp (TSE:WEED – Get Free Report)’s share price hit a new 52-week low during mid-day trading on Thursday. The stock traded as low as C$1.17 and last traded at C$1.19, with a volume of 746527 shares traded. The stock had previously closed at C$1.26.
Analyst Ratings Changes
Separately, Alliance Global Partners cut their price objective on Canopy Growth from C$1.80 to C$1.60 in a report on Tuesday, June 16th. Two equities research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of C$1.88.
View Our Latest Research Report on WEED
Canopy Growth Trading Down 6.3%
Canopy Growth (TSE:WEED – Get Free Report) last released its earnings results on Friday, August 7th. The company reported C($0.03) earnings per share (EPS) for the quarter. Canopy Growth had a negative return on equity of 29.85% and a negative net margin of 73.95%.The firm had revenue of C$81.17 million for the quarter. Equities analysts predict that Canopy Growth Corp will post -0.69 earnings per share for the current year.
Insider Buying and Selling
In other Canopy Growth news, Director David Angelo Lazzarato sold 22,380 shares of the company’s stock in a transaction that occurred on Monday, September 28th. The stock was sold at an average price of C$1.29, for a total transaction of C$28,870.20. Following the completion of the transaction, the director owned 108,237 shares of the company’s stock, valued at C$139,625.73. This represents a 17.13% decrease in their position. In the last quarter, insiders sold 43,492 shares of company stock valued at $56,105. Insiders own 0.21% of the company’s stock.
Canopy Growth Company Profile
Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names. It also offers its products through Tweed Main Street, a single online platform that enables registered patients to purchase medicinal cannabis from various producers across various brands.
Further Reading
- Five stocks we like better than Canopy Growth
- PepsiCo Stock Looks Poised to Bottom With High Yield, Deep Value
- Alphabet’s $1.8 Billion Black Hills Deal Powers AI Data Center Push
- This Space ETF Offers SpaceX Exposure—But Investors Are Paying for the Volatilit
- Does Lemonade’s Growth Signal Profits Ahead?
Receive News & Ratings for Canopy Growth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Canopy Growth and related companies with MarketBeat.com's FREE daily email newsletter.
